Several lines of evidence suggest that a decline of serum testosterone levels occur in the aging male. This condition is called late-onset hypogonadism (LOH). Current guidelines suggest testosterone replacement therapy (TRT) when total testosterone (TT) is lower than 9.2 nmol/L. However, the clinical management of patients showing signs and symptoms suggestive for LOH but with TT in the lowest quartile of the normal range and/or having higher than the expected testosterone annual reduction velocity is not covered. This editorial aims to discuss this hot topic, suggesting a possible management.
Symptomatic late-onset hypogonadism but normal total testosterone: the importance of testosterone annual decrease velocity
Sandro La Vignera;Rosita A. Condorelli;Aldo E. Calogero;Rossella Cannarella;Laura M. Mongioì;Ylenia Duca;Laura Cimino;Filippo Giacone;
2019-01-01
Abstract
Several lines of evidence suggest that a decline of serum testosterone levels occur in the aging male. This condition is called late-onset hypogonadism (LOH). Current guidelines suggest testosterone replacement therapy (TRT) when total testosterone (TT) is lower than 9.2 nmol/L. However, the clinical management of patients showing signs and symptoms suggestive for LOH but with TT in the lowest quartile of the normal range and/or having higher than the expected testosterone annual reduction velocity is not covered. This editorial aims to discuss this hot topic, suggesting a possible management.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
462_La-Vignera.pdf
accesso aperto
Tipologia:
Versione Editoriale (PDF)
Dimensione
171.18 kB
Formato
Adobe PDF
|
171.18 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.